AI
Thursday, March 24, 2011 7:21:28 AM
OK maybe you'd get 30% but I think its much closer to that then say paying a 100% premium. Actually I could never put a finger on it but something has bothered me about the company (maybe Price speaks too smoothly 
) but as we have seen you get a few serious AE's in one of their drugs or Roche bails and investors will get scared and shareholders would be wishing for even current prices for a buyout . The field is still very competitive (HCV in general) and they don't have a compound in Phase 3 yet I think its pretty risky at this point for a $3B buyout.
) but as we have seen you get a few serious AE's in one of their drugs or Roche bails and investors will get scared and shareholders would be wishing for even current prices for a buyout . The field is still very competitive (HCV in general) and they don't have a compound in Phase 3 yet I think its pretty risky at this point for a $3B buyout.
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
